Regeneron Pharmaceuticals | REGN - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
AbbVie USD 508.97B 46.71B 2026-11
Agenus USD 128M 21M 2026-03
Agios Pharmaceuticals USD 1.79B 420M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Astellas Pharma JPY 4.78T 582.95B 2026-11
AstraZeneca USD 213.88B 23.43B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.95B 667M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Eli Lilly USD 1.09T 40.33B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 653.61B 42.25B 2026-09
Kyowa Hakko Kirin JPY 1.3T 99.97B 2026-11
Merck USD 375.59B 17.09B 2026-11
Neurocrine Biosciences USD 14.46B 45M 2026-11
Novartis USD 292.09B 51.5B 2026-09
Novartis USD 328.21B 54.92B 2026-11
Pfizer USD 169.88B 6.47B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 114.34B 15.65B 2026-11
Sarepta Therapeutics USD 1.77B 129M 2026-11
Teva Pharmaceutical Industries USD 152.12B 105.39B 2026-11
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
United Therapeutics USD 28.64B 5.4B 2026-11
Vertex Pharmaceuticals USD 142.88B 10.37B 2026-11